Increased expression of preproneuropeptide Y and preprosomatostatin mRNA in striatum after selective serotoninergic lesions in rats

Neurosci Lett. 1993 Oct 1;160(2):197-200. doi: 10.1016/0304-3940(93)90412-e.

Abstract

The levels of neuropeptide Y and somatostatin may change when serotoninergic neurotransmission is altered in different brain regions. To assess whether serotonin regulates the synthesis of these peptides, we measured the levels of preproneuropeptide Y (ppNPY) and preprosomatostatin (ppSOM) mRNA in different brain regions after intracerebroventricular injection of 5,7-dihydroxytryptamine (5,7-DHT), a selective serotonin neurotoxin. The mRNA of these peptides significantly increased in the striatum but not in hippocampus and frontal cortex. It thus appears that serotonin has an inhibitory effect on the biosynthesis of neuropeptide Y and somatostatin in striatum whereas it probably acts by stimulating the release of these peptides in hippocampus and frontal cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,7-Dihydroxytryptamine / toxicity
  • Animals
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • Corpus Striatum / metabolism*
  • Frontal Lobe / metabolism
  • Gene Expression / drug effects
  • Gene Expression / physiology*
  • Hippocampus / metabolism*
  • Male
  • Neuropeptide Y / biosynthesis*
  • Organ Specificity
  • Protein Precursors / biosynthesis*
  • RNA, Messenger / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Somatostatin / biosynthesis*

Substances

  • Neuropeptide Y
  • Protein Precursors
  • RNA, Messenger
  • 5,7-Dihydroxytryptamine
  • Somatostatin
  • preproneuropeptide Y